Examples of 'paritaprevir' in a sentence
Meaning of "paritaprevir"
paritaprevir (noun) - A direct-acting antiviral medication used in the treatment of hepatitis C
Show more definitions
- An acylsulfonamide inhibitor of the NS3-4A serine protease, under investigation for the treatment of hepatitis C.
How to use "paritaprevir" in a sentence
Basic
Advanced
paritaprevir
This action makes paritaprevir more effective.
Paritaprevir was positive in an in vitro human chromosome aberration test.
Inhibition by ritonavir and increase in paritaprevir.
Paritaprevir the risks see section.
Caution is advised due to the expected increase in paritaprevir exposures.
Increase in paritaprevir exposures may be due to.
Metabolism as well as biliary excretion of parent drug contribute to the elimination of paritaprevir.
Increase in paritaprevir exposures may be due to inhibition of OATPs by atazanavir.
Inhibition by paritaprevir.
Tacrolimus whole blood concentrations should be monitored upon initiation ombitasvir paritaprevir.
Ombitasvir and paritaprevir block two proteins essential for the virus to multiply.
No dose adjustment needed for Viekirax with ombitasvir paritaprevir.
Paritaprevir Hydrate has very low water solubility.
Clinical Comments itonavir dasabuvir ombitasvir paritaprevir.
Paritaprevir and dasabuvir are substrates of BCRP.
See also
Norgestrel ↑ nor elgestromine ombitasvir paritaprevir.
Paritaprevir was discovered during the ongoing collaboration between AbbVie and Enanta Pharmaceuticals NASDAQ.
It contains the active substances ombitasvir, paritaprevir and ritonavir.
Ombitasvir, paritaprevir and ritonavir are highly bound to plasma proteins.
Ritonavir acts as a ‘ booster ' to prolong the action of paritaprevir in the body.
Ombitasvir, paritaprevir and ritonavir should be administered with food.
Total daily dose of ciclosporin once daily with ombitasvir / paritaprevir.
Paritaprevir - derived material was minimally transferred through the placenta in pregnant rats.
Viekirax contains the active substances ombitasvir, paritaprevir and ritonavir.
Changes for ombitasvir, paritaprevir and dasabuvir the same as shown for paracetamol above.
Exviera safety and efficacy have been established in combination with ombitasvir / paritaprevir.
Ombitasvir, paritaprevir and ritonavir are coformulated into one tablet ; dasabuvir has its own tablet.
Cokiera is an antiviral medicine containing the active substances dasabuvir, ombitasvir, paritaprevir and ritonavir.
All clinical trials with ombitasvir, paritaprevir and ritonavir have been conducted following administration with food.
Paritaprevir is a substrate of CYP3A and transport proteins.
Mechanism, Increase in paritaprevir exposures may be due to.
Treatment with darunavir + Viekirax without dasabuvir is not ombitasvir paritaprevir.
Mechanism, Increase in paritaprevir exposures may be due to inhibition of.
Ritonavir is a CYP3A inhibitor that increases the systemic exposure of the CYP3A substrate paritaprevir.
Mechanism, Increase in paritaprevir exposures may be due to inhibition of OATPs by atazanavir.
CYP3A4 inhibition by ritonavir and increase in paritaprevir exposures may be due to.
Clinical Comments paritaprevir changes during treatment with Exviera ombitasvir / paritaprevir / ritonavir.
Mechanism, Intestinal Pgp inhibition by paritaprevir and ritonavir.
Regimens with paritaprevir / ritonavir + dasabuvir resulted.
Dabigatran etexilate Mechanism, Intestinal Pgp inhibition by paritaprevir and ritonavir.
The absolute bioavailability of ombitasvir and paritaprevir was approximately 50 % when administered with food as Viekirax.
Paritaprevir the same time as dasabuvir +ombitasvir/paritaprevi r/ritonavir.
For interactions with ombitasvir / paritaprevir / ritonavir refer to the Summary of Product Characteristics.
Exviera is administered with ombitasvir / paritaprevir / ritonavir.
S-warfarin paritaprevir ombitasvir.
Dasabuvir is administered with ombitasvir/ paritaprevir /ritonavir.
Ombitasvir, paritaprevir and ritonavir are substrates of P-gp.
CYP2C8 inhibition and increase in paritaprevir is possibly due to.
Paritaprevir the same time as Exviera +ombitasvir/paritaprevi r/ritonavir.
Strong inhibitors of CYP3A may significantly increase paritaprevir and ritonavir exposures when co-administered with TECHNIVIE.
